186 related articles for article (PubMed ID: 28801558)
1. Visceral adiposity index, lipid accumulation product and intracranial atherosclerotic stenosis in middle-aged and elderly Chinese.
Li R; Li Q; Cui M; Ying Z; Li L; Zhong T; Huo Y; Xie P
Sci Rep; 2017 Aug; 7(1):7951. PubMed ID: 28801558
[TBL] [Abstract][Full Text] [Related]
2. Higher visceral adiposity index and lipid accumulation product in relation to increased risk of atherosclerotic burden in community-dwelling older adults.
Sun J; Meng X; Huang H; Jing J; Pan Y; Mei L; Jin A; Wang Y; Wei T; Cai X
Exp Gerontol; 2023 Apr; 174():112115. PubMed ID: 36758647
[TBL] [Abstract][Full Text] [Related]
3. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China.
Muheiyati G; Mei Y; Tao N
PeerJ; 2023; 11():e15273. PubMed ID: 37214102
[TBL] [Abstract][Full Text] [Related]
4. Visceral adiposity index and lipid accumulation product as a predictor of type 2 diabetes mellitus: The Bogor cohort study of non-communicable diseases risk factors.
Nusrianto R; Ayundini G; Kristanti M; Astrella C; Amalina N; Muhadi ; Riyadina W; Tahapary DL; Soewondo P
Diabetes Res Clin Pract; 2019 Sep; 155():107798. PubMed ID: 31330161
[TBL] [Abstract][Full Text] [Related]
5. Visceral Adiposity Index and Lipid Accumulation Product Index: Two Alternate Body Indices to Identify Chronic Kidney Disease among the Rural Population in Northeast China.
Dai D; Chang Y; Chen Y; Chen S; Yu S; Guo X; Sun Y
Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27983609
[TBL] [Abstract][Full Text] [Related]
6. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
7. Association of Visceral Obesity Indices With Incident Diabetic Retinopathy in Patients With Diabetes: Prospective Cohort Study.
Chen J; Li YT; Niu Z; He Z; Xie YJ; Hernandez J; Huang W; Wang HHX;
JMIR Public Health Surveill; 2024 Feb; 10():e48120. PubMed ID: 38319705
[TBL] [Abstract][Full Text] [Related]
8. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
9. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
10. Clinical surrogate markers for predicting metabolic syndrome in middle-aged and elderly Chinese.
Li R; Li Q; Cui M; Yin Z; Li L; Zhong T; Huo Y; Xie P
J Diabetes Investig; 2018 Mar; 9(2):411-418. PubMed ID: 28664593
[TBL] [Abstract][Full Text] [Related]
11. Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population.
Gu Z; Zhu P; Wang Q; He H; Xu J; Zhang L; Li D; Wang J; Hu X; Ji G; Zhang L; Liu B
Lipids Health Dis; 2018 Dec; 17(1):289. PubMed ID: 30572889
[TBL] [Abstract][Full Text] [Related]
12. Associations of lipid accumulation product, visceral adiposity index, and triglyceride-glucose index with subclinical organ damage in healthy Chinese adults.
Du MF; Zhang X; Hu GL; Mu JJ; Chu C; Liao YY; Chen C; Wang D; Ma Q; Yan Y; Jia H; Wang KK; Sun Y; Niu ZJ; Man ZY; Wang L; Zhang XY; Luo WJ; Gao WH; Li H; Wu GJ; Gao K; Zhang J; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1164592. PubMed ID: 37795361
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of visceral adiposity indices and lipid accumulation products in the identification of adults at high cardiovascular risk.
Milla AMG; Chagas EBF; Miola VFB; Zanuso BO; Guiguer EL; Araújo AC; Tofano RJ; Quesada KR; Laurindo LF; Barbalho SM
Clin Investig Arterioscler; 2023; 35(5):236-242. PubMed ID: 37121826
[TBL] [Abstract][Full Text] [Related]
14. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients.
Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A
Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690
[No Abstract] [Full Text] [Related]
15. Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA study.
Kouli GM; Panagiotakos DB; Kyrou I; Georgousopoulou EN; Chrysohoou C; Tsigos C; Tousoulis D; Pitsavos C
Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):881-889. PubMed ID: 28851556
[TBL] [Abstract][Full Text] [Related]
16. Assessment of visceral adiposity index and lipid accumulation product index as markers of chronic kidney disease among diabetic and hypertensive patients at the Bamenda Regional Hospital, Cameroon: a cross-sectional study.
Choumessi AT; Saha BUF; Navti LK; Tibi AS; Njeck AT; Nantia EA
Pan Afr Med J; 2022; 42():228. PubMed ID: 36845245
[TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes.
Ahn N; Baumeister SE; Amann U; Rathmann W; Peters A; Huth C; Thorand B; Meisinger C
Sci Rep; 2019 Jul; 9(1):9693. PubMed ID: 31273286
[TBL] [Abstract][Full Text] [Related]
18. Lipid accumulation product, visceral adiposity index and risk of chronic kidney disease.
Bullen AL; Katz R; Kumar U; Gutierrez OM; Sarnak MJ; Kramer HJ; Shlipak MG; Ix JH; Judd SE; Cushman M; Garimella PS
BMC Nephrol; 2022 Dec; 23(1):401. PubMed ID: 36522626
[TBL] [Abstract][Full Text] [Related]
19. Lipid Accumulation Product Predicts Diabetes Remission After Bariatric Surgery in Chinese Patients with BMI < 35 kg/m
Yi X; Ling J; Meng H; Wu L; Zhu S; Zhu L
Obes Surg; 2022 Jun; 32(6):1935-1943. PubMed ID: 35397038
[TBL] [Abstract][Full Text] [Related]
20. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
